Anaplastic large cell lymphoma (ALCL), a distinct subtype of T-cell non-Hodgkin lymphoma, has been the subject of vigorous research efforts over recent years. Investigations have focused on improving ...

National population-based analysis of demographics and outcomes of patients diagnosed with extranodal NK/T-cell nasal type lymphoma in the US: Does ethnicity play a role? This is an ASCO Meeting ...

A collaboration between scientists from St. Jude Children's Research Hospital and Dana-Farber Cancer Institute uncovered four proteins that govern the identity of anaplastic large cell lymphoma (ALCL) ...

The incidence of a rare cancer, anaplastic large-cell lymphoma (ALCL), has surged in recent years, possibly because of the growing use of textured breast implants. Considering this trend, some breast ...

Breast implant-associated anaplastic large cell lymphoma (BIA-ALCL) is a rare T‐cell lymphoma that emerges in the periprosthetic capsule surrounding breast implants, particularly those with a textured ...

Interactive Effects of Molecular, Therapeutic, and Patient Factors on Outcome of Diffuse Low-Grade Glioma The 2-year event-free survival (EFS) is 76.8% (95% CI, 68.5 to 88.1) and the 2-year overall ...

A 10-year-old boy who has been receiving cancer treatment at East Tennessee Children’s Hospital has finished his chemo treatement. Jensen Vaught was diagnosed with Anaplastic Large Cell Lymphoma, a ...

The global T-Cell lymphoma therapeutics market size was valued at US$ 2.3 Bn in 2024 and is projected to reach US$ 5.7 Bn by ...